Kiora Pharmaceuticals's total assets for Q2 2025 were $31.95M, a decrease of -6.10% from the previous quarter. KPRX total liabilities were $9.82M for the fiscal quarter, a -4.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.